Table 1.
Characteristics, imaging and echocardiogram of the four reported patients.
| Variable | Patient 1 | Patient 2 | Patient 3 | Patient 4 |
|---|---|---|---|---|
| Age | 60 | 59 | 55 | 59 |
| Sex | Female | Male | Male | Male |
| Risk factors for stroke | Diabetes mellitus type 2, hypertension | No known Risk Factors | Diabetes mellitus type 2, hypertension | Hypertension, DM and cardiac mass |
| Medications | Aspirin | – | Aspirin | – |
| NIHSS initial | 6 | 7 | 4 | 30 |
| NIHSS 24 h | 4 | 6 | 4 | 28 |
| NIHSS discharge | 3 | – | 4 | – |
| Outcome | Rehab | Deceased | Rehab, for cervical spinal stenosis | Deceased |
| Stroke symptom and signs | Right sided facial droop and weakness | Right sided facial droop and weakness | Presented with quadriparesis, has severe cervical spine stenosis | Right sided weakness |
| Imaging result | MRI Brain: bilateral embolic tiny cortical infarcts in different vascular territories. | CT head: Embolic infarcts in the left parieto-occipital area | MRI brain: multiple small infarcts in the centrum semiovale of the bilateral frontoparietal lobes suggestive of watershed infarcts | MRI brain: Multiple infarcts in bilateral medullar, left occipital lobe and right parahippocampal region |
| Vessel imaging | No evidence of LVO or ICAD | No evidence of LVO or ICAD | Intracranial atherosclerosis | Occlusion of the right vertebral artery |
| Acute treatment of stroke | TPA | No tPA or endovascular therapy | No tPA or endovascular therapy | No tPA or endovascular therapy |
| Treatment of COVID | Azithromycin Toclizumab | Tocilizumab | Hydroxychloroquine and azithromycin | Remdesivir and dexamethasone |
| COVID-19 symptoms | Fever, cough and shortness of breath | cough, dyspnea and confusion | Fever, cough and shortness of breath | Shortness of breath |
| ICU admission | Yes | Yes | No | Yes |
| Transthoracic Echocardiogram | Normal | Not done | Pending | Not done |